Author: Mack, Ethan A.; Kallal, Lara E.; Demers, Delia A.; Biron, Christine A.
Title: Type 1 Interferon Induction of Natural Killer Cell Gamma Interferon Production for Defense during Lymphocytic Choriomeningitis Virus Infection Document date: 2011_8_9
ID: qkwo747o_3
Snippet: With the hypothesis that type 1 IFN induction of NK cell IFN-⥠is in place to access low, regional levels of the cytokine as infections are initiated, studies were undertaken to examine responses at the earliest times of viral infection under immunocompetent conditions. The system used for study was intraperitoneal (i.p.) infection of C57BL/6 (B6) mice with lymphocytic choriomeningitis virus (LCMV) (7, 9, 16, 17) . This infection has been well .....
Document: With the hypothesis that type 1 IFN induction of NK cell IFN-⥠is in place to access low, regional levels of the cytokine as infections are initiated, studies were undertaken to examine responses at the earliest times of viral infection under immunocompetent conditions. The system used for study was intraperitoneal (i.p.) infection of C57BL/6 (B6) mice with lymphocytic choriomeningitis virus (LCMV) (7, 9, 16, 17) . This infection has been well characterized and is of relevance to the human condition because LCMV can cause significant morbidity and mortality, particularly in immunodeficient individuals (18) (19) (20) . The virus is a potent inducer of type 1 IFN, with systemic levels produced in serum and spleen for several days after i.p. infection (7, 9, 17) . In contrast, LCMV is a poor inducer of IL-12, with low to undetectable levels of the cytokine produced (8, 16) , and NK cell IFN-⥠expression is also low to undetectable in the serum and spleens of LCMV-infected mice (8, 9) . Because the initial site of virus entry is the peritoneal cavity, the studies focused on previously uncharacterized events at this location.
Search related documents:
Co phrase search for related documents- potent inducer and virus entry: 1
- regional level and response examine: 1
- regional level and significant morbidity: 1, 2
- regional level and study system: 1, 2, 3
- regional level and viral infection: 1, 2
- response examine and viral infection: 1, 2, 3, 4, 5, 6, 7, 8
- serum produce and viral infection: 1
- significant morbidity and study system: 1, 2, 3, 4
- significant morbidity and systemic level: 1
- significant morbidity and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- significant morbidity and virus entry: 1, 2, 3, 4
- spleen serum and viral infection: 1, 2, 3
- study system and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- study system and virus entry: 1, 2, 3, 4, 5, 6
- systemic level and viral infection: 1, 2
- systemic level and virus entry: 1, 2
- undetectable level and viral infection: 1
- viral infection and virus entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- viral infection and virus entry initial site: 1
Co phrase search for related documents, hyperlinks ordered by date